UniProtKB/Swiss-Prot P07498: Variant p.Ala145Thr

Kappa-casein
Gene: CSN3
Feedback?

Variant information Variant position:

145 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

LB/B The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Alanine (A) to Threonine (T) at position 145 (A145T, p.Ala145Thr). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from small size and hydrophobic (A) to medium size and polar (T) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Other resources:

Links to websites of interest for the variant.

Variant rs3775739 [ dbSNP | Ensembl ]

Sequence information Variant position:

145 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

182 The length of the canonical sequence.
Location on the sequence:

IQDKIIIPTINTIATVEPTP A PATEPTVDSVVTPEAFSESI The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         IQDKIIIPTINTIATVEPT--PAPAT------EPTVDSVVTPEAFSESI

Mouse                         NQDNTAIPTIDPITPIVST--PVPTM------ESIVNTVAN

Rat                           KHDNTAIPASNTIAPIVST--PVSTT------ESVVNTVAN

Pig                           NQDKTAIPAINSIATVEPT--IVPATEPIVNAEPIVNAVVT

Bovine                        NQDKTEIPTINTIASGEPT--STPTT------EAVESTVAT

Rabbit                        MQDKAVTPTTNTIAAVEPT--PIPTT------EPVVSTEVI

Goat                          DQDKTEVPAINTIASAEPTVHSTPTT------EAIVNTVDN

Sheep                         DQDKTEIPAINTIASAEPTVHSTPTT------EAVVNAVDN

Horse                         LQEITVIPKINTIATVEPT--PIPTP------EPTVNNAVI

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	21 – 182	Kappa-casein
Modified residue	157 – 157	Phosphothreonine; alternate
Glycosylation	133 – 133	O-linked (GalNAc...) threonine
Glycosylation	143 – 143	O-linked (GalNAc...) threonine
Glycosylation	148 – 148	O-linked (GalNAc...) threonine
Glycosylation	151 – 151	O-linked (GalNAc...) threonine
Glycosylation	157 – 157	O-linked (GalNAc...) threonine; alternate

Literature citations
Submission
Menon R.S.; Jeffers K.F.; Chang Y.F.; Ham R.G.;
Cited for: NUCLEOTIDE SEQUENCE [MRNA]; VARIANT THR-145;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.